Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 44 records per page: next > | last >>
pages: 1 2 3 4 5 ... 41 42 43 44 presentations: 1 to 25 of 1084
Opening Ceremony
Opening Remarks
Margaret Foti, Ph.D., M.D. (h.c.)
American Association for Cancer Research, Philadelphia, PA
President's Remarks
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Inst., Boston, MA
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
Sixth Annual AACR Team Science Award
Team Science Award Presentation
The ICR and Royal Marsden Hospital: CRUK Cancer Therapeutics & Drug Development Units
Institute of Cancer Research, Sutton, United Kingdom
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
Distinguished Service Award
Introduction
Margaret Foti, Ph.D., M.D. (h.c.)
American Association for Cancer Research, Philadelphia, PA
Acceptance Speech
Bayard Clarkson, M.D.
Mem. Sloan-Kettering Cancer Ctr., New York, NY
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
Tribute to Evelyn H. Lauder
Introduction
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Inst., Boston, MA
Tribute to Evelyn H. Lauder
Larry Norton, M.D.
Mem. Sloan-Kettering Cancer Ctr., New York, NY
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
Sixth Annual AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
Opening Ceremony Award Presentation
John Mendelsohn
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
Ninth Annual AACR Award for Lifetime Achievement in Cancer Research
  •  
  • Permission not
    granted for presentation
  •  
  •  
Acceptance Speech
Beatrice Mintz
Fox Chase Cancer Center, Philadelphia, PA, United States
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
Honoring 50-year Members and Distinguished Public Service
Introduction of 50-year Members
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Inst., Boston, MA
Introduction of Distinguished Public Service
Margaret Foti, Ph.D., M.D. (h.c.)
American Association for Cancer Research, Philadelphia, PA
Acceptance Speech
Giuseppe Bernardi, M.D.
Pezcoller Foundation, Trento, Italy
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
Accelerating Science Video
AACR Annual Meeting 2012 Opening Video
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
Closing Remarks
Judy Garber, M.D., M.P.H.
Dana-Farber Cancer Inst., Boston, MA
from AACR Annual Meeting 2012 on April 1, 2012 8:15 AM-9:00 AM
The Cancer Biology Revolution: From Concept to Clinic
Emerging landscape of the tumor genome
Elaine Mardis
Washington Univ. School of Medicine, Saint Louis, MO, United States
from AACR Annual Meeting 2012 on April 1, 2012 9:15 AM-12:15 PM
The Cancer Biology Revolution: From Concept to Clinic
The genetic basis for cancer therapeutics
William R. Sellers
Novartis Insts. for BioMedical Research, Cambridge, MA, United States
from AACR Annual Meeting 2012 on April 1, 2012 9:15 AM-12:15 PM
The Cancer Biology Revolution: From Concept to Clinic
Therapeutic targeting of B cell receptor signaling in activated B cell-like (ABC) diffuse large B cell lymphoma with the BTK inhibitor Ibrutinib (PCI-32765)
Louis M Staudt
NCI-CCR, Bethesda, MD, United States
from AACR Annual Meeting 2012 on April 1, 2012 9:15 AM-12:15 PM
The Cancer Biology Revolution: From Concept to Clinic
Discussant
Jonathan D Licht
Northwestern Univ. Lurie Comp. Cancer Ctr., Chicago, IL, United States
from AACR Annual Meeting 2012 on April 1, 2012 9:15 AM-12:15 PM
The Cancer Biology Revolution: From Concept to Clinic
Mobilizing the immune system to treat cancer: New insights and opportunities
James P. Allison
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2012 on April 1, 2012 9:15 AM-12:15 PM
The Cancer Biology Revolution: From Concept to Clinic
Human papillomavirus in the etiology and prevention of genital cancers
Nubia Muñoz
Former IARC Epidemiologist, Lyon, France
from AACR Annual Meeting 2012 on April 1, 2012 9:15 AM-12:15 PM
The Cancer Biology Revolution: From Concept to Clinic
  •  
  • Permission not
    granted for presentation
  •  
  •  
Molecular mechanisms of epigenetic inheritance
Danny F. Reinberg
NYU Langone Medical Center, New York, NY, United States
from AACR Annual Meeting 2012 on April 1, 2012 9:15 AM-12:15 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study
Dejan Juric
Massachusetts General Hospital Cancer Center, Boston, MA, United States
from AACR Annual Meeting 2012 on April 1, 2012 3:15 PM-5:25 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Discussant
Lillian L. Siu
University Health Network Ontario Cancer Institute, Toronto, ON, Canada
from AACR Annual Meeting 2012 on April 1, 2012 3:15 PM-5:25 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
A phase I, open label, dose escalation study of oral mammalian target of rapamycin inhibitor INK128 administered by intermittent dosing regimens in patients with advanced malignancies
Josep Tabernero
Vall d’Hebron Institue of Oncology, Barcelona, Spain
from AACR Annual Meeting 2012 on April 1, 2012 3:15 PM-5:25 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Discussant
Fabrice Andre
Institut Gustave Roussy, Villejuif, France
from AACR Annual Meeting 2012 on April 1, 2012 3:15 PM-5:25 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer
Funda Meric-Bernstam
UT M.D. Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2012 on April 1, 2012 3:15 PM-5:25 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Discussant
Carlos L. Arteaga
Vanderbilt-Ingram Cancer Ctr., Nashville, TN, United States
from AACR Annual Meeting 2012 on April 1, 2012 3:15 PM-5:25 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
  •  
  • Permission not
    granted for presentation
  •  
  •  
A phase II study of neoadjuvant metformin in prostatic carcinoma
Anthony M. Joshua
Princess Margaret Hospital, Toronto, ON, Canada
from AACR Annual Meeting 2012 on April 1, 2012 3:15 PM-5:25 PM
Clinical Trials Symposium 1: Clinical Trials of Agents Directed Towards PI3K and Metabolic Pathways
Discussant
Howard Scher
Memorial Sloan Kettering Cancer Center, NY, United States
from AACR Annual Meeting 2012 on April 1, 2012 3:15 PM-5:25 PM
Advances in Chemoprevention
Breast cancer prevention: Targeting hormone and signaling pathways
Powel H. Brown
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2012 on March 31, 2012 8:00 AM-10:00 AM
<< first | < prev page: of 44 records per page: next > | last >>
pages: 1 2 3 4 5 ... 41 42 43 44 presentations: 1 to 25 of 1084